Literature DB >> 10923237

Cholelithiasis in a newborn following treatment with the somatostatin analogue octreotide.

G Radetti, L Gentili, C Paganini, H Messner.   

Abstract

We report the case of a newborn infant affected by congenital hyperinsulinism who developed cholelithiasis associated with cholestatic jaundice following treatment with octreotide, a somatostatin analogue.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10923237     DOI： 10.1007/s004310051335

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  7 in total

1.  Case files of the Medical Toxicology Fellowship Training Program at the Children's Hospital of Philadelphia: a pediatric exploratory sulfonylurea ingestion.

Authors:  Diane P Calello; Andrea Kelly; Kevin C Osterhoudt
Journal:  J Med Toxicol       Date:  2006-03

Review 2.  Management strategies for neonatal hypoglycemia.

Authors:  Courtney B Sweet; Stephanie Grayson; Mark Polak
Journal:  J Pediatr Pharmacol Ther       Date:  2013-07

Review 3.  Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review.

Authors:  Charles C Roehr; Andreas Jung; Hans Proquitté; Oliver Blankenstein; Hannes Hammer; Kokila Lakhoo; Roland R Wauer
Journal:  Intensive Care Med       Date:  2006-03-11       Impact factor: 17.440

Review 4.  Octreotide and enterocutaneous fistula closure in neonates and children.

Authors:  Noela Carrera-Guermeur; Rosa M Martín-Crespo; Hilda J Ramírez; Ángel Pantoja; Rafael Luque-Mialdea
Journal:  Eur J Pediatr       Date:  2016-01-26       Impact factor: 3.183

5.  Safety of octreotide in hospitalized infants.

Authors:  Daniela Testoni; Christoph P Hornik; Megan L Neely; Qinghong Yang; Ann W McMahon; Reese H Clark; P Brian Smith
Journal:  Early Hum Dev       Date:  2015-05-15       Impact factor: 2.699

Review 6.  Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia.

Authors:  Basma Haris; Saras Saraswathi; Khalid Hussain
Journal:  Ther Adv Endocrinol Metab       Date:  2020-12-02       Impact factor: 3.565

Review 7.  Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers.

Authors:  Alena Welters; Christian Lerch; Sebastian Kummer; Jan Marquard; Burak Salgin; Ertan Mayatepek; Thomas Meissner
Journal:  Orphanet J Rare Dis       Date:  2015-11-25       Impact factor: 4.123
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.